Plain-English translation of NCT06497153 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →This trial is testing whether lung ultrasound—a safe, bedside imaging technique—can help doctors better understand and manage acute chest syndrome, a serious lung complication that affects many children with sickle cell disease. The study will use ultrasound scans to measure how well the lungs are working and see if this information can guide decisions about oxygen support and blood transfusions.
Acute chest syndrome is one of the most serious complications of sickle cell disease and a leading reason children need intensive care. Right now, doctors don't have clear guidelines about when and how to support breathing or when to give transfusions, so this study aims to use ultrasound imaging to help doctors make better, more personalized treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you join this study, doctors will perform lung ultrasound scans as part of your regular care in the intensive care unit—this is a painless bedside procedure with no radiation. They will take measurements of how your lungs are airing and compare these results to other markers of how sick you are, such as how much oxygen you need and how you're breathing. The ultrasound findings may help your doctors decide on the best breathing support and transfusion plan for you.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
France